Homepage >>>

    Healthcare Q&A: Chris Garabedian on Sarepta’s Plans for Eteplirsen

    Chris Garabedian, President and Chief Executive Officer of Sarepta, told Bloomberg Brief: Healthcare Finance’s Elizabeth Krutoholow that the results seen with lead drug eteplirsen for Duchenne Muscular Dystrophy (DMD) have provided proof-of-concept to support the company’s phosphorodiamidate morpholino oligomer technology. He said the company will focus on DMD and eventually other rare genetic diseases. Sarepta [...]


    Download China Brief

    Download the 12/3/12 China Brief here


    Principal Financial Targets Bank Exit

    By Dana Wilkie Principal Financial Group Inc., the seller of life insurance and retirement products, is seeking to exit banking to limit U.S. oversight. The insurer filed a draft application to end its status as a savings and loan holding company to avoid Federal Reserve regulation that may limit investing and require the Des Moines, Iowa-based company to [...]


    Credit Suisse Seeks UCITS Hedge Funds for Multi-Manager Programs

    Credit Suisse AG is searching for equity long/short and fixed incomerelated absolute return strategies to add to its pair of UCITS-only multi-manager programs, according to Oliver Wiedemeijer, portfolio manager of the programs. To continue reading click here:


    Patriot Shows Futility of Moving Cases from NY

    By Bill Rochelle Bankruptcy Judge Shelley Chapman in New York transferred venue of the Patriot Coal Corp. reorganization to St. Louis this week. Saying she had “considerable regret” about the move, Chapman really had no choice. Patriot incorporated two subsidiaries in New York on the eve of bankruptcy. Otherwise, there were no venue “hooks” in New York. [...]


    LBO Volume May Rise by Up to 70% in 2013

    Leveraged buyout volume could rise by 25 to 70 percent in 2013, pending resolution of the fiscal cliff. Investment banks are approaching consulting firms such as Alvarez & Marsal, which advises both buyers and sellers on LBOs, for due diligence on companies intended to be sold in the first quarter of next year. To continue reading click here


    Sales of Notes Tied to Global Stock Basket Surge

    U.S. investors are buying 65 percent more notes linked to a basket of U.K., European and Japanese stock indexes this year, spurred by a 12 percent average gain in the benchmarks since May. Banks have sold $908 million of U.S. notes tied to the Euro Stoxx 50 Index of the 50 largest euro-area companies, the U.K.’s FTSE 100 Index, and Japan’s Tokyo Stock Price Index, known as the Topix [...]


    Western Wind Seen Luring Bids to Top Offer

    Traders are betting Western Wind Energy Corp.’s executives will persuade suitors to top what’s already the most expensive valuation for an alternative-energy takeover on record. Shares of Western Wind, the Vancouver-based operator and developer of wind farms and solar projects that put itself up for sale in July, closed yesterday 11 percent above a C$2.50-a-share proposal from Brookfield [...]


    Apollo to Increase LPs’ Share of Fees in New Fund

    Apollo Global Management LLC will give investors a greater share of deal fees in its next flagship fund than it offered in the past, according to two people familiar with the situation and fund documents viewed by Bloomberg News. Apollo Investment Fund VIII LP, which is seeking $12 billion, will direct 80 percent of fees it charges portfolio [...]


    Gramercy Starts Distressed Fund With $200 Million

    Gramercy Advisors LLC, the $3.2 billion emerging-markets hedge fund, started a distressed credit fund with $200 million in commitments, according to a letter to investors, a copy of which was obtained by Bloomberg News. The Gramercy Distressed Opportunity Fund II invests in stressed performing, distressed and defaulted emerging market corporate and sovereign debt, Robert Koenigsberger, managing partner and chief [...]


1 2 3 56 57 58 59 60 61 62 72 73 74

Bloomberg BRIEF Newsletters